SCHEMBL23867487

SCHEMBL23867487

Cc1cc(Nc2ccc(NC(=O)Cc3cccc4ccccc34)cc2)nc(N2CCOCC2)n1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.67
▸ KDM4E B2RXH2 4/20 0.67
▸ MEN1 O00255 1/20 0.67
▸ KMT2A Q03164 1/20 0.67
▸ LMNA P02545 5/20 0.59
▸ ALDH1A1 P00352 5/20 0.58
▸ HSD17B10 Q99714 2/20 0.58
▸ HPGD P15428 1/20 0.58
▸ ALOX15 P16050 1/20 0.58
▸ MAPK1 P28482 1/20 0.55
▸ TAAR1 Q96RJ0 1/20 0.55
▸ NPSR1 Q6W5P4 2/20 0.52
▸ POLB P06746 1/20 0.52
▸ PKM P14618 1/20 0.51
▸ ACHE P22303 1/20 0.48
▸ IGF1R P08069 1/20 0.48
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ GLA P06280 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30979648 0.82 POLB (0.66) MAPTKDM4EMEN1KMT2ALMNA
SCHEMBL23867551 0.80 LMNA (0.61) MAPTKDM4ELMNAALDH1A1HSD17B10
SCHEMBL31094224 0.78 SLC2A1 (0.51) MAPTKDM4EMEN1KMT2ALMNA
SCHEMBL30234299 0.75 LMNA (0.65) MAPTKDM4ELMNAALDH1A1HSD17B10
SCHEMBL31094227 0.75 SLC2A1 (0.44) MAPTKDM4EMEN1KMT2ALMNA
SCHEMBL23859942 0.74 POLB (0.55) MAPTKDM4EMEN1KMT2ALMNA
SCHEMBL23867524 0.74 HCRTR1 (0.52) MAPTKDM4EMEN1KMT2ALMNA
SCHEMBL23867523 0.74 SLC2A1 (0.49) MAPTKDM4ELMNAALDH1A1HSD17B10
SCHEMBL23867576 0.73 LMNA (0.52) MAPTKDM4ELMNAALDH1A1HSD17B10
SCHEMBL30979651 0.72 SLC2A1 (0.51) MAPTKDM4EMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021195279-A2 SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2021-09-30 — — WO disclosed
Send feedback